These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 38032)

  • 21. Proceedings: Effect on prolactin secretion of thyrotrophin releasing factor.
    Hall TR; Chadwick A
    J Endocrinol; 1974 Nov; 63(2):45P. PubMed ID: 4216620
    [No Abstract]   [Full Text] [Related]  

  • 22. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of serum prolactin analysis].
    Aono T; Kurachi K
    Nihon Rinsho; 1983 May; 41(5):1035-40. PubMed ID: 6415321
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of naloxone on TRH-induced PRL and TSH response in normal man.
    Rampinini A; Iannotta F; Rizzuto G; Colombo F; Giuliani F; Parabiaghi R
    Minerva Endocrinol; 1989; 14(2):125-8. PubMed ID: 2503692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine, PIF, and other regulators of prolactin secretion.
    Clemens JA; Shaar CJ; Smalstig EB
    Fed Proc; 1980 Sep; 39(11):2907-11. PubMed ID: 6105975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyrotropin-releasing hormone (TRH) is the major prolactin-releasing factor in the bullfrog hypothalamus.
    Nakajima K; Uchida D; Sakai M; Takahashi N; Yanagisawa T; Yamamoto K; Kikuyama S
    Gen Comp Endocrinol; 1993 Jan; 89(1):11-6. PubMed ID: 8428643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
    Chouinard G; Annable L; Jones BD; Collu R
    Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic regulation of thyrotropin release in uremic patients.
    Leu ML; Huang BY; Huang HS; Kao SL
    Taiwan Yi Xue Hui Za Zhi; 1984 Jun; 83(6):556-64. PubMed ID: 6436433
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolactin control in Huntington's chorea.
    Müller EE; Cocchi D; Mantegazza P; Parati EA; Caraceni T
    Lancet; 1977 Oct; 2(8041):764-5. PubMed ID: 71573
    [No Abstract]   [Full Text] [Related]  

  • 30. The prolactin secretory response to neuroleptic drugs: mechanisms, applications and limitations.
    Rubin RT; Hays SE
    Psychoneuroendocrinology; 1980; 5(2):121-37. PubMed ID: 6104835
    [No Abstract]   [Full Text] [Related]  

  • 31. Examining the dopamine hypotheses of schizophrenia and of mania using the prolactin response to antipsychotic drugs.
    Silverstone T; Cookson J
    Neuropharmacology; 1983 Apr; 22(4):539-41. PubMed ID: 6134252
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroleptic drugs and the sigma receptor.
    Hoffman DW
    Am J Psychiatry; 1990 Aug; 147(8):1093-4. PubMed ID: 1973876
    [No Abstract]   [Full Text] [Related]  

  • 33. Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess.
    Hayden MR; Vinik AI; Paul M; Beighton P
    Lancet; 1977 Aug; 2(8035):423-6. PubMed ID: 70642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dopaminergic receptors in the brain].
    Alexandrová M
    Cesk Fysiol; 1984; 33(3):227-40. PubMed ID: 6147203
    [No Abstract]   [Full Text] [Related]  

  • 35. Targets for neurotransmitter receptor research using PET scan: the neuroleptic binding site.
    Baron JC; Martinot JL; Cambon H; Boulenger JP; Poirier MF; Caillard V; Blin J; Huret JD; Loc'h C; Maziere B
    Psychopharmacol Ser; 1989; 7():20-31. PubMed ID: 2574449
    [No Abstract]   [Full Text] [Related]  

  • 36. A dopamine-dependent restitutive system for the maintenance of mental normalcy.
    Friedhoff AJ
    Ann N Y Acad Sci; 1986; 463():47-52. PubMed ID: 2872848
    [No Abstract]   [Full Text] [Related]  

  • 37. Animal prolactin evidence for antipsychotic activity of piperoxane.
    Gold MS; Redmond DE; Donabedian RK
    Lancet; 1977 Jul; 2(8028):96-7. PubMed ID: 69186
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of DN-1417 (TRH analog) on schizophrenic patients].
    Mizuki Y; Takada Y; Tsujimaru H; Takii O; Nishijima H
    Seishin Shinkeigaku Zasshi; 1983; 85(11):808-12. PubMed ID: 6146149
    [No Abstract]   [Full Text] [Related]  

  • 39. Bone mineral density and prolactin associations in patients with chronic schizophrenia.
    Abraham G; Halbreich U; Friedman RH; Josiassen RC
    Schizophr Res; 2003 Jan; 59(1):17-8. PubMed ID: 12413637
    [No Abstract]   [Full Text] [Related]  

  • 40. Decrease in serum-prolactin after propranolol in schizophrenia.
    Hanssen T; Heyden T; Sundberg I; Wetterberg L; Eneroth P
    Lancet; 1978 Jan; 1(8055):101-2. PubMed ID: 74547
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.